Test Price
2,800 AED✅ Home Collection Available
GPC3 Gene Sequencing for Simpson-Golabi-Behmel Syndrome Type 1 – Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The GPC3 gene Simpson-Golabi-Behmel syndrome type 1 NGS test provides comprehensive gene sequencing to detect pathogenic variants associated with this X-linked overgrowth disorder. This test is crucial for Neurologists evaluating developmental delays and neurological manifestations, Oncologists assessing embryonal tumor risk, and Clinical Geneticists for accurate family counselling and carrier screening. Laboratory operations are accredited ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
| Feature | Our Test (NGS GPC3) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | >99.9% Sensitivity & Specificity | ~99% but limited to known hotspots |
| Methodology | Next Generation Sequencing (NGS) with full gene coverage | Targeted Sanger sequencing of selected exons |
| Turnaround Time | 3-4 Weeks | 6-8 Weeks (if multiple exons needed) |
Physician Insight & Safety Protocols
"I understand that considering genetic testing for a rare condition like Simpson-Golabi-Behmel syndrome can be emotionally challenging. Our advanced NGS analysis provides a thorough evaluation of the GPC3 gene, enabling early diagnosis and personalized management. I strongly recommend correlating results with clinical findings and genetic counseling."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medical Advisory
Do not discontinue any prescribed medication without consulting your healthcare provider. If you are on anticoagulant therapy, please inform our phlebotomist prior to sample collection.
Exclusion Criteria & Red Flags
- Testing for minors requires explicit parental/guardian consent in accordance with UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Patients with bleeding disorders or anti-coagulant therapy must inform the phlebotomist prior to sample collection.
- Seek immediate medical attention if you experience suicidal ideation, severe anxiety, or psychological distress related to genetic results.
Red Flag: A positive result may warrant urgent oncology surveillance; contact your specialist without delay.
Patient FAQ & Clinical Guidance
1. What is the purpose of the GPC3 gene test for Simpson-Golabi-Behmel syndrome?
This NGS test analyzes the entire GPC3 gene to identify pathogenic variants causing Simpson-Golabi-Behmel syndrome type 1, an X-linked overgrowth disorder associated with developmental delays and tumor risk.
It aids in confirming clinical diagnosis, guiding surveillance for embryonal tumors, and enabling carrier testing for family members.
2. How should I prepare for the blood sample collection?
No fasting is required; simply ensure you are well-hydrated and inform our team about any anticoagulant medications before the home collection appointment.
Our phlebotomist will use a cold-chain transport kit to preserve DNA integrity. A genetic counselling session to draw a family pedigree is recommended prior to testing.
3. Will my insurance cover this genetic test?
Many UAE insurers cover genetic testing for clinically indicated conditions; our direct billing verification via WhatsApp confirms your policy’s pre-approval status before scheduling.
Contact +971 54 548 8731 to receive instant verification and avoid out-of-pocket surprises.
UAE Regulatory & Data Privacy Adherence
This test service operates in full compliance with UAE data protection and healthcare regulations, including:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring secure handling of your genetic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing the use of digital health systems.
All clinical testing and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | GPC3 Gene Sequencing for Simpson-Golabi-Behmel Syndrome Type 1 |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3-4 Weeks |
| Sample Type / Matrix | Peripheral blood (Whole blood in EDTA tube) |
| Methodology Used | Next Generation Sequencing (NGS) with full gene coverage |
| ICD-10-CM Code | Q87.89 |
| LOINC Code | 90900-1 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians